Article
Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Document Type
Article
Publication Date
5-25-2020
Disciplines
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
Specialty/Research Institute
Earle A. Chiles Research Institute
Citation Information
Katherine Sanchez, Shu-Ching Chang, Isaac Kim, Maritza Martel, et al.. "Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2020) Available at: http://works.bepress.com/walter-urba/290/